Financings in Brief: EndoSonics
This article was originally published in The Gray Sheet
Executive Summary
EndoSonics: Pleasanton, California-based catheter and intravascular imaging system manufacturer files registration statement with the Securities and Exchange Commission for a secondary offering of 2.3 mil. shares of common stock. Stock in EndoSonics closed at 13-1/2 on Oct. 13, the day the offering was announced. Piper Jaffray and Volpe, Welty & Co. are lead underwriters, EndoSonics says, noting that underwriters have an overallotment option to buy 345,000 additional shares...
You may also be interested in...
EU’s SCCS Finds Endocrine-Disrupting Evidence Inconclusive In UV Filter Reassessments
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
US FDA Urges COVID-19 Transmission Risk Mitigation In Cell And Gene Therapy Manufacturing
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
COVID-19: US Acted To Beat Other Countries To Next 1.25M Doses Of Regeneron Cocktail
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: